Disability icon

Disability

Core data points

At a glance

11 patient groups shared a commentary
32% Regularly or sometimes engage with drug regulators
13 Comments / feedback
3 Sub-types of disability represented
9 Countries represented
~114.2K Approximate number of patients reached by these groups

Survey insights

Of the 25 disability patient groups, 32% represent patient interests to drug regulators. Leading activities include advocating for fair medicine pricing, addressing cost barriers for low-income and vulnerable people and/or equitable access to healthcare (each 18%).

Patient groups representing each Disability sub-type

25 patient groups across 3 sub-types

  • most types 10
  • other 4
  • young people 2

Patient group voices

Patient group goals

The percentages below highlight how the 11 patient groups interact with regulators and advocate for patient interests. As respondents may be represented in more than one area, percentages may not total 100%.

interactions

How patient groups interact with drug regulators

Find out what the goals mean
3 mentions
1 mention
1 mention
actions & advocacy

How patient groups get access to medicines

Find out what the goals mean
5 mentions
2 mentions
1 mention

GET THE REPORT

Access the full findings

Our research covers 2,262 patient groups representing 100 countries and 45 therapy areas. The sample report shows you the depth of analysis for a single country or therapy area. To access any other reports, please get in touch.

Visit patient-view.com to gather more information or email: Alex Wyke, alexwyke@patient-view.com